Skip to main content

Therapy and clinical trials.

Publication ,  Journal Article
Chongthammakun, V; Krasuski, RA
Published in: Curr Opin Lipidol
October 2014

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Curr Opin Lipidol

DOI

EISSN

1473-6535

Publication Date

October 2014

Volume

25

Issue

5

Start / End Page

410 / 411

Location

England

Related Subject Headings

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Guidelines as Topic
  • Diabetes Mellitus
  • Clinical Trials as Topic
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • 3205 Medical biochemistry and metabolomics
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chongthammakun, V., & Krasuski, R. A. (2014). Therapy and clinical trials. Curr Opin Lipidol, 25(5), 410–411. https://doi.org/10.1097/MOL.0000000000000116
Chongthammakun, Vasutakarn, and Richard A. Krasuski. “Therapy and clinical trials.Curr Opin Lipidol 25, no. 5 (October 2014): 410–11. https://doi.org/10.1097/MOL.0000000000000116.
Chongthammakun V, Krasuski RA. Therapy and clinical trials. Curr Opin Lipidol. 2014 Oct;25(5):410–1.
Chongthammakun, Vasutakarn, and Richard A. Krasuski. “Therapy and clinical trials.Curr Opin Lipidol, vol. 25, no. 5, Oct. 2014, pp. 410–11. Pubmed, doi:10.1097/MOL.0000000000000116.
Chongthammakun V, Krasuski RA. Therapy and clinical trials. Curr Opin Lipidol. 2014 Oct;25(5):410–411.

Published In

Curr Opin Lipidol

DOI

EISSN

1473-6535

Publication Date

October 2014

Volume

25

Issue

5

Start / End Page

410 / 411

Location

England

Related Subject Headings

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Guidelines as Topic
  • Diabetes Mellitus
  • Clinical Trials as Topic
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • 3205 Medical biochemistry and metabolomics
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences